IFP Advisors’s BioCardia BCDA Stock Holding History

IFP Advisors’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$1K	–	3446
2022 Q4	$1K	Hold	7	–	–	﹤0.01%	4287
2022 Q3	$1K	Hold	7	–	–	﹤0.01%	4506
2022 Q2	$1K	Hold	7	–	–	﹤0.01%	4282
2022 Q1	$1K	Buy	+7	New	+$208	﹤0.01%	4282

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IFP Advisors's BCDA Position: Q1 2023 in Review

IFP Advisors sold out of BioCardia (BCDA) in Q1 2023, closing a stake of 7 shares — an estimated $1K sold.

IFP Advisors first reported a position in BCDA in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2022. 23 funds tracked by Wall St. Rank hold BCDA as of Q1 2023.

IFP Advisors reported no remaining BioCardia position as of Q1 2023 after selling out during the quarter.
IFP Advisors sold 7 BioCardia shares in Q1 2023, an estimated $1K.
IFP Advisors first reported a position in BioCardia in Q1 2022 and held it in 4 quarters.
IFP Advisors's BioCardia position peaked at $1K in Q4 2022.
23 funds tracked by Wall St. Rank held BioCardia as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.